… , these cytokine-stimulated dendritic cells have been successfully … use of dendritic cell
immunotherapy for the treatment of brain … that treatment of tumor-bearing rats with dendritic cells …

… Dendritic cells (DCs) are critical for the robust presentation of immunogenic peptides and
activation of T cells. Citation38 DCs can be generated from human peripheral blood …

… Electron micrograph of a human follicular dendritic cell. The nucleus is moderately irregular
and possesses much euchromatin while several cytoplasmic processes project from the …

… Treatment with rhlL-4 caused many MOMC to develop morphologic properties of dendritic
cells … In contrast, calcium ionophore (CI) treatment induced rapid and consistent effects in …

… dendritic cell– based immunotherapy can treat murine HCC effectively. Bone marrow–derived
dendritic cells … The dendritic cells were pulsed with a Hepa1-6 lysate overnight and em…

… to therapy is often disappointing and new modalities of treatment are clearly needed. Active
immunotherapy based on the injection of autologous dendritic cells (DC) co-cultured ex vivo …

… , we have examined whether treatment of patients with metastatic melanoma with matured
dendritic cell (DC) vaccines with or without low dose IL-2 may improve treatment outcomes. …

… and may represent key pathways to target in optimized treatment regimens against cancer.
… , stressed, or injured cells [2, 3]. Dendritic cells (DCs) are a minor cell population of distinct …

… Dendritic cells (DCs) are immune specialized cells playing a critical … therapy approaches
for cancer treatment paradigms. … Manufacturing cells to be used as drugs for patient treatment …

… activator, immunostimulatory DNA, and a tumor antigen to activate and load dendritic cells
… dendritic cells but also prolongs their survival in vivo and in vitro. Following treatment of mice …